| Old Articles: <Older 3601-3610 Newer> |
|---|
 |
The Motley Fool
April 11, 2007
Billy Fisher |
A Replacement for Vioxx at Merck? Drug company has new pain medication in the pipeline. If Arcoxia is approved despite the long odds against it, it could payoff over the long run for Merck shareholders.   |
Fast Company
March 15, 2007
Tinker Ready |
Not Invented Here The next blockbuster drug could come from anywhere. It's up to Merck's scouts to find it. |
The Motley Fool
April 10, 2007
Brian Lawler |
Barr Issues a Challenge Barr challenges the patents on one of Sanofi's top drugs. |
BusinessWeek
April 16, 2007
Arlene Weintraub |
Big Pharma's Animal Spirits Sales of medicine for pets and livestock are giving drugmakers a welcome boost. |
BusinessWeek
April 16, 2007
Catherine Arnst |
Health Care For All? Not Quite Maine's two-year-old universal health care system Dirigo is providing other states with a blueprint and useful lessons. |
BusinessWeek
April 16, 2007
Dunham & Epstein |
Stopping Reform Before It Starts Small biz is emerging as a powerful opponent of universal health care. |
InternetNews
April 5, 2007
Andy Patrizio |
PlayStation 3 Users Power on to Cure Disease Sony PlayStation 3 users have been cranking computer power to help Stanford University-sponsored project Folding@Home project achieve its goal: simulating protein misfolding in an attempt to understand disease. |
The Motley Fool
April 5, 2007
Brian Lawler |
ImClone Steps to the Front ImClone announces a successful clinical trial for the cancer drug Erbitux. Investors, take note. |
InternetNews
April 4, 2007
David Needle |
USB Looks For Healthcare Edge Standards group works on spec to make it easier to connect healthcare devices. |
The Motley Fool
April 4, 2007
Brian Lawler |
Novartis Gets Nicked Novartis pulls one of its top-selling drugs from the market. Investors should come to expect drug delays or similar issues popping up from time to time when doing their analysis of large pharmas. |
| <Older 3601-3610 Newer> Return to current articles. |
